Page last updated: 2024-09-04

olmesartan and Renal Insufficiency, Chronic

olmesartan has been researched along with Renal Insufficiency, Chronic in 21 studies

Research

Studies (21)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's20 (95.24)24.3611
2020's1 (4.76)2.80

Authors

AuthorsStudies
Abe, E; Azushima, K; Hashimoto, T; Kamimura, D; Kinguchi, S; Nakano, M; Sano, D; Suzuki, T; Taguchi, S; Tamura, K; Tanaka, S; Tsukamoto, S; Urate, S; Wakui, H; Yamada, T; Yamaji, T; Yamashita, A1
Bakris, G; Deedwania, P; Reimitz, PE; Weber, M1
van der Merwe, WM1
Hirooka, Y; Nishihara, M; Takesue, K1
Higashi, K; Kumagai, H; Kushiyama, T; Miura, S; Oda, T; Oshima, N; Sakurai, Y; Takechi, H; Uchida, T; Watanabe, A; Yamamoto, K1
Hiramatsu, K; Ishikawa, Y; Kario, K; Kobayashi, F; Kushiro, T; Saito, I; Shimada, K; Teramukai, S1
Hiramatsu, K; Kario, K; Kobayashi, F; Kushiro, T; Mori, Y; Saito, I; Shimada, K; Teramukai, S1
Chrysant, SG1
Adamcová, M; Arendášová, K; Aziriová, S; Bárta, A; Celec, P; Hrenák, J; Kamodyová, N; Krajčírovičová, K; Paulis, L; Rajkovičová, R; Repová, K; Simko, F1
Etminan, M; Eurich, DT; Lin, M; Padwal, R1
Izumikawa, Y; Kato, H; Kojima, K; Kubo, E; Nagura, M; Nosaka, H; Shima, T; Shimada, M; Shiraishi, T; Tanemoto, M; Tomioka, S; Uchida, S; Ueda, S; Yano, H1
Chin, HJ; Choi, BS; Hwang, JH; Kim, DK; Kim, S; Lee, SH; Lim, CS; Park, JH; Shin, SJ1
Baek, SH; Chin, HJ; Choi, BS; Kim, DK; Kim, S; Lee, SH; Lim, CS; Park, JH; Shin, SJ1
Kario, K; Kushiro, T; Okuda, Y; Saito, I; Sato, Y; Shimada, K; Teramukai, S1
Hasegawa, Y; Kim-Mitsuyama, S; Nakagawa, T; Uekawa, K1
Dohi, Y; Kimura, G; Miyagawa, K; Nakazawa, A; Sato, K; Sugiura, T; Yamashita, S1
Fujino, M; Imaizumi, S; Karnik, SS; Kiya, Y; Miura, S; Saku, K1
Chetsurakarn, S; Eiam-Ong, S; Limkuansuwan, P; Manotham, K; Ongvilawan, B; Tanamai, J; Tungsanga, K; Urusopone, P1
Azushima, K; Fujikawa, T; Kanaoka, T; Kobori, H; Maeda, A; Ohsawa, M; Tamura, K; Umemura, S; Wakui, H; Yanagi, M1
Miura, S; Saku, K1
Arima, H; Iseki, K; Kohagura, K; Komiya, I; Shiohira, Y; Tokuyama, K; Toma, S; Ueda, S; Uehara, H1

Reviews

2 review(s) available for olmesartan and Renal Insufficiency, Chronic

ArticleYear
Olmesartan-based monotherapy vs combination therapy in hypertension: A meta-analysis based on age and chronic kidney disease status.
    Journal of clinical hypertension (Greenwich, Conn.), 2017, Volume: 19, Issue:12

    Topics: Age Factors; Antihypertensive Agents; Drug Therapy, Combination; Humans; Hypertension; Imidazoles; Renal Insufficiency, Chronic; Tetrazoles; Treatment Outcome

2017
Effectiveness of the fixed-dose combination of olmesartan/amlodipine/hydrochlorothiazide for the treatment of hypertension in patients stratified by age, race and diabetes, CKD and chronic CVD.
    Expert review of cardiovascular therapy, 2013, Volume: 11, Issue:9

    Topics: Age Factors; Amlodipine; Cardiovascular Diseases; Diabetes Complications; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Renal Insufficiency, Chronic; Tetrazoles

2013

Trials

7 trial(s) available for olmesartan and Renal Insufficiency, Chronic

ArticleYear
Effect of the angiotensin II receptor antagonist olmesartan on morning home blood pressure in hypertension: HONEST study at 16 weeks.
    Journal of human hypertension, 2013, Volume: 27, Issue:12

    Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Blood Pressure; Diabetes Complications; Female; Heart Rate; Humans; Hypertension; Imidazoles; Male; Middle Aged; Prospective Studies; Renal Insufficiency, Chronic; Tetrazoles; Time Factors

2013
Effects of intensive low-salt diet education on albuminuria among nondiabetic patients with hypertension treated with olmesartan: a single-blinded randomized, controlled trial.
    Clinical journal of the American Society of Nephrology : CJASN, 2014, Dec-05, Volume: 9, Issue:12

    Topics: Adult; Aged; Albuminuria; Angiotensin II Type 1 Receptor Blockers; Blood Pressure; Diet, Sodium-Restricted; Female; Food; Humans; Hypertension; Imidazoles; Male; Medication Adherence; Middle Aged; Patient Education as Topic; Renal Insufficiency, Chronic; Single-Blind Method; Sodium; Sodium, Dietary; Surveys and Questionnaires; Tetrazoles

2014
A low-salt diet increases the estimated net endogenous acid production in nondiabetic chronic kidney disease patients treated with angiotensin receptor blockade.
    Nephron. Clinical practice, 2014, Volume: 128, Issue:3-4

    Topics: Acid-Base Equilibrium; Angiotensin II Type 1 Receptor Blockers; Diet, Sodium-Restricted; Disease Progression; Female; Humans; Imidazoles; Male; Middle Aged; Prospective Studies; Renal Insufficiency, Chronic; Tetrazoles; Treatment Outcome; Urinalysis

2014
Renoprotective effect of calcium channel blockers in combination with an angiotensin receptor blocker in elderly patients with hypertension. A randomized crossover trial between benidipine and amlodipine.
    Clinical and experimental hypertension (New York, N.Y. : 1993), 2010, Volume: 32, Issue:1

    Topics: Aged; Aged, 80 and over; Albuminuria; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Cross-Over Studies; Dihydropyridines; Drug Therapy, Combination; Female; Humans; Hypertension; Imidazoles; Male; Renal Insufficiency, Chronic; Tetrazoles

2010
Clinical and pharmacotherapeutic relevance of the double-chain domain of the angiotensin II type 1 receptor blocker olmesartan.
    Clinical and experimental hypertension (New York, N.Y. : 1993), 2010, Volume: 32, Issue:2

    Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Animals; Binding Sites; Blood Pressure; Female; Heart Rate; Humans; Hydrogen Bonding; Hypertension; Imidazoles; Male; Middle Aged; Models, Molecular; Rats; Rats, Inbred Dahl; Receptor, Angiotensin, Type 1; Renal Insufficiency, Chronic; Static Electricity; Tetrazoles

2010
The angiotensin II type 1 receptor blocker olmesartan preferentially improves nocturnal hypertension and proteinuria in chronic kidney disease.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2013, Volume: 36, Issue:3

    Topics: Aged; Albuminuria; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Pressure; Circadian Rhythm; Collagen Type IV; Comorbidity; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Humans; Hypertension; Imidazoles; Kidney; Male; Middle Aged; Proteinuria; Renal Insufficiency, Chronic; Tetrazoles

2013
Effects of angiotensin receptor blockade (ARB) on mortality and cardiovascular outcomes in patients with long-term haemodialysis: a randomized controlled trial.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2013, Volume: 28, Issue:6

    Topics: Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Cardiovascular Diseases; Case-Control Studies; Female; Humans; Hypertension; Imidazoles; Male; Middle Aged; Prognosis; Prospective Studies; Renal Dialysis; Renal Insufficiency, Chronic; Survival Rate; Tetrazoles; Young Adult

2013

Other Studies

12 other study(ies) available for olmesartan and Renal Insufficiency, Chronic

ArticleYear
Tissue-specific expression of the SARS-CoV-2 receptor, angiotensin-converting enzyme 2, in mouse models of chronic kidney disease.
    Scientific reports, 2021, 08-19, Volume: 11, Issue:1

    Topics: Adenine; Angiotensin-Converting Enzyme 2; Animals; Aristolochic Acids; COVID-19; Disease Models, Animal; Down-Regulation; Humans; Imidazoles; Kidney; Mice; Mice, Inbred C57BL; Organ Specificity; Renal Insufficiency, Chronic; SARS-CoV-2; Tetrazoles

2021
Treatment of hypertension in CKD patients with azilsartan/chlorthalidone vs olmesartan/hydrochlorothiazide.
    Journal of clinical hypertension (Greenwich, Conn.), 2018, Volume: 20, Issue:4

    Topics: Antihypertensive Agents; Benzimidazoles; Chlorthalidone; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Olmesartan Medoxomil; Oxadiazoles; Renal Insufficiency, Chronic; Tetrazoles

2018
Olmesartan combined with renal denervation reduces blood pressure in association with sympatho-inhibitory and aldosterone-reducing effects in hypertensive mice with chronic kidney disease.
    Clinical and experimental hypertension (New York, N.Y. : 1993), 2019, Volume: 41, Issue:3

    Topics: Albuminuria; Aldosterone; Animals; Antihypertensive Agents; Blood Pressure; Body Weight; Combined Modality Therapy; Heart; Hypertension; Imidazoles; Kidney; Male; Mice; Mice, Inbred ICR; Nephrectomy; Organ Size; Renal Insufficiency, Chronic; Renin-Angiotensin System; Sympathectomy; Sympathetic Nervous System; Tetrazoles

2019
Protective effects of Rho kinase inhibitor fasudil on rats with chronic kidney disease.
    American journal of physiology. Renal physiology, 2013, Jun-01, Volume: 304, Issue:11

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Actins; Angiotensin II Type 1 Receptor Blockers; Animals; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Enzyme Inhibitors; Hypercholesterolemia; Imidazoles; Kidney Glomerulus; Lectins, C-Type; Macrophages; Male; Mannose Receptor; Mannose-Binding Lectins; Membrane Proteins; Microscopy, Electron; Phenotype; Proteinuria; Rats; Receptors, Cell Surface; Renal Insufficiency, Chronic; rho-Associated Kinases; RNA, Messenger; Tetrazoles

2013
Enhanced blood pressure-lowering effect of olmesartan in hypertensive patients with chronic kidney disease-associated sympathetic hyperactivity: HONEST study.
    Journal of clinical hypertension (Greenwich, Conn.), 2013, Volume: 15, Issue:8

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Female; Follow-Up Studies; Heart Rate; Humans; Hypertension; Imidazoles; Male; Middle Aged; Prospective Studies; Renal Insufficiency, Chronic; Sympathetic Nervous System; Tetrazoles; Young Adult

2013
Protective effect of captopril, olmesartan, melatonin and compound 21 on doxorubicin-induced nephrotoxicity in rats.
    Physiological research, 2013, Volume: 62, Issue:Suppl 1

    Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antioxidants; Captopril; Doxorubicin; Glomerular Filtration Rate; Imidazoles; Male; Melatonin; Oxidative Stress; Rats; Rats, Wistar; Reactive Oxygen Species; Receptor, Angiotensin, Type 2; Renal Agents; Renal Insufficiency, Chronic; Tetrazoles; Treatment Outcome

2013
Comparative effectiveness of olmesartan and other angiotensin receptor blockers in diabetes mellitus: retrospective cohort study.
    Hypertension (Dallas, Tex. : 1979), 2014, Volume: 63, Issue:5

    Topics: Adult; Angiotensin Receptor Antagonists; Cardiovascular Diseases; Cohort Studies; Comorbidity; Diabetes Mellitus; Female; Gastrointestinal Diseases; Hospitalization; Humans; Hypertension; Imidazoles; Male; Middle Aged; Proportional Hazards Models; Registries; Renal Insufficiency, Chronic; Retrospective Studies; Risk Factors; Survival Rate; Tetrazoles; Treatment Outcome; United States

2014
Blood pressure control and satisfaction of hypertensive patients following a switch to combined drugs of an angiotensin receptor blocker and a calcium channel blocker in clinical practice of nephrology.
    Clinical and experimental nephrology, 2015, Volume: 19, Issue:3

    Topics: Aged; Amlodipine; Angiotensin Receptor Antagonists; Azetidinecarboxylic Acid; Benzimidazoles; Benzoates; Biphenyl Compounds; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Drug Combinations; Drug Costs; Drug Substitution; Female; Humans; Hypertension; Imidazoles; Male; Medication Adherence; Middle Aged; Nephrology; Patient Satisfaction; Practice Patterns, Physicians'; Renal Insufficiency, Chronic; Retrospective Studies; Surveys and Questionnaires; Telmisartan; Tetrazoles; Valsartan

2015
Increased cardiovascular risk of treated white coat and masked hypertension in patients with diabetes and chronic kidney disease: the HONEST Study.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2017, Volume: 40, Issue:1

    Topics: Aged; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Cardiovascular Diseases; Cardiovascular System; Diabetes Mellitus, Type 2; Female; Humans; Imidazoles; Male; Masked Hypertension; Middle Aged; Prospective Studies; Renal Insufficiency, Chronic; Risk Factors; Tetrazoles; White Coat Hypertension

2017
Chronic kidney disease accelerates cognitive impairment in a mouse model of Alzheimer's disease, through angiotensin II.
    Experimental gerontology, 2017, Volume: 87, Issue:Pt A

    Topics: Aging; Alzheimer Disease; Angiotensin II Type 1 Receptor Blockers; Animals; Blood-Brain Barrier; Cognition; Cognitive Dysfunction; Disease Models, Animal; Hippocampus; Imidazoles; Maze Learning; Memory; Mice; Mice, Transgenic; Oxidative Stress; Renal Insufficiency, Chronic; Tetrazoles

2017
Angiotensin II receptor blocker partially ameliorated intrarenal hypoxia in chronic kidney disease patients: a pre-/post-study.
    Internal medicine journal, 2012, Volume: 42, Issue:4

    Topics: Adult; Angiotensin Receptor Antagonists; Diabetic Nephropathies; Female; Humans; Hypoxia; Imidazoles; Kidney; Magnetic Resonance Imaging; Male; Middle Aged; Oxygen; Renal Insufficiency, Chronic; Tetrazoles; Young Adult

2012
How important is it to control nocturnal hypertension with angiotensin II type 1 receptor blockers?
    Hypertension research : official journal of the Japanese Society of Hypertension, 2013, Volume: 36, Issue:3

    Topics: Angiotensin II Type 1 Receptor Blockers; Blood Pressure; Circadian Rhythm; Female; Humans; Hypertension; Imidazoles; Male; Proteinuria; Renal Insufficiency, Chronic; Tetrazoles

2013